PR Newswire
WILMINGTON, Del., April 30, 2026
In just a short span of time cannabis business is estimated to be one of this decade’s fastest growing and disruptive opportunities due to several reasons emerging from Internal regulatory reform leading toward legalization across North America and Europe increasing awareness among consumers as well as health professionals regarding therapeutic benefits; favourable investments ecosystem (including venture capitalists) enhancing readiness for medical use with surging R&D investment.
WILMINGTON, Del., April 30, 2026 /PRNewswire/ — Allied Market Research published a report titled, ‘Cannabis Market by Product Type (Buds or Marijuana Flower, Cannabis Extracts), by Compound (THC-Dominant, Balanced THC & CBD, CBD-Dominant), by Application (Medical, Recreational, Others): Global Opportunity Analysis and Industry Forecast, 2022-2031.’ According to the report, the global Cannabis Market size was valued at $25.7 billion in 2021 and is estimated to reach $148.9 billion by 2031, growing at a CAGR of 20.1% from 2022 to 2031.
https://mma.prnewswire.com/media/636519/5918347/Allied_Market_Research_Logo.jpg
Request the Sample PDF of this Report: https://www.alliedmarketresearch.com/request-sample/A16908
Key Market Snapshot
Metric
Value
Market Size (2021)
$25.7 Billion
Market Forecast (2031)
$148.9 Billion
CAGR (2022-2031) 20.1 %
Leading Product Segment Cannabis Extracts ($13,794.3 Mn in 2021; CAGR
20.4%)
Leading Compound Segment
Balanced THC & CBD (CAGR 19.8%)
Fastest-Growing Compound
THC-Dominant (CAGR 20.4%)
Leading Application Segment Recreational ($13,873.2 Mn in 2021; CAGR
19.7%)
Fastest-Growing Application
Medical (CAGR 21.1%)
Dominant Region
North America (CAGR 17.6%)
Fastest-Growing Region
LAMEA (CAGR 32.3%)
Growth Drivers
The Cannabis Market, with a size of $25.7 billion in 2021 is expected to grow almost six times in scale up by the year 2030 such growth trajectory reflects the unprecedented structural change taking place across global regulatory, scientific and consumer landscapes at once. Cannabis, also called marijuana is a herbal medicine from plants in the Cannabis species that diagnosed to treat various symptoms and diseases like cancer, chronic pain and mental disorders. Tetrahydrocannabinol (THC) and cannabidiol are herbal-derived vs cannabis medicinal active substances from the two most abundant cannabinoids in this plant. FDA imposed multiple regulations, and new laws in place will allow cannabis use legally under control.
This growth at a CAGR of 20.1% is underpinned by three structural drivers: legalization of cannabis in an increasing number of countries, consumer awareness around the health benefits associated with CBD and its growing therapeutic usage, innovative products through broadened product development efforts; Together, these forces are creating a compounding demand environment that is accelerating rather than moderating as the forecast period unfolds.
Key Market Insights
In 2021, the cannabis extracts segment generated the highest revenue of $13,794.3 million and is projected to reach $82,309.1 million by 2031 growing at a CAGR of 20.4%.
By Compound, the balanced THC & CBD segment accounted for $11,976.5 million of total revenue in 2021 and is estimated to reach $$67,909.8 by 2031 at a CAGR of19.8%.
In terms of application, the recreational segment was valued at $13,873.2 million in 2021 and estimates to reach $78,013.0 million by 2031 registering a CAGR of 19.7% during the forecast period
By region, North America was highest revenue generating is expected to generate a total of $22,115.3 million in 2021 and estimated at $104 billion by 2031 while Growing the fastest with CAGR of17•6% for nextten year)
The LAMEA region is anticipated to grow with the fastest CAGR of 32.3% over the forecast period.
Procure Complete Report (250 Pages PDF with Insights, Charts, Tables, and Figures) @
https://www.alliedmarketresearch.com/checkout-final/5e9953e5e504d317c05e62356825b138
Segment Analysis
By Product Type
The cannabis extracts segment held the largest share of 66.7% in 2021 and is expected to retain its leading position during the forecast period, based on product type. Furthermore, the same segment is predicted to mention during the forecast period at a rapid CAGR of 20.4%. Cannabis extracts are concentrates made with a solvent. In order to create a cannabis extract solvents that are most commonly used include butane, propane, ethanol and supercritical carbon dioxide. Although all extracts are concentrates but not all concentrates is extract.
By Compound
On the basis of compound, the balanced THC and CBD segment accounted for nearly half share in 2021, was able to grab nearly one-third market globally throughout from both segments & is anticipated to hold its leading position during future years. Conversely, the THC dominated segment is anticipated to report highest CAGR of 20.4% during forecast period.
By Application
The recreational segment contributed the highest revenue to the market, with $13,873.2 million in 2021 and is projected to reach $78,013.0 million by 2031 at a CAGR of 19.7%. Cannabis is used recreationally for pleasure reasons or indulging in the drug, rather than medicinal purposes. However, the medical component is projected to report a highest CAGR of 21.1 % in the duration time from now on.
Regional Insights
North America: By region, North America was the largest revenue holder in 2021 at $22,115.3 million and is expected to reach the highest value of $104,403.3 Million by 2031 growing at a CAGR of18% throughout with this growth pattern continuing into subsequent decades due internal increases from many systems where originally models became even more complicated over time! This was attributed to the legalization of cannabis for medical and recreational use in both U.S. and Canada, as well as increase in demand due to rising prevalence of conditions treated with medicinal Cannabis market throughout North America such as epilepsy cancer multiple sclerosis last post-traumatic stress disorder chronic pain depression or social anxiety. Due to legalization of cannabis in both the U.S. and Canada for medical as well as recreational purposes, together with rise in research & development (R&D) activities pertaining to the medicinal applications of cannabis North America is projected to remain a lucrative market during forecast period.
Asia-Pacific: With most North American, European and South American countries already embraced the emerging cannabis industry it leaves a large window of opportunity for Asia-Pacific to be next up in legalising this miracle plant. Being one of the primary markets for industrial hemp, New Zealand is expected to evolve into a legal market for commercialisation of business to use cannabis. Legislating in the region are expecting large scales of growth among several focused businesses within the cannabis sector. Some other countries in the region could serve as affordable, high-efficiency cannabis suppliers. China, already a powerhouse in industrial hemp is expected to become one of the largest markets for industrial cannabis soon.
Europe: The European Cannabis Industry landscape represents a key, strategically important market that is increasingly supported by favourable regulation in many European countries coupled with growing populations of medical cannabis patients benefiting from better access to treatment across Germany, the Netherlands and the UK amongst others. To date, roughly 20 states in America have legalized medical cannabis and several others around the world recently passed laws decriminalizing its use. New and needlessly convoluted consulting on CBD legislation at a European level is increasingly working against the effective pan-European delivery systems for medicines that have emerged in this post-pandemic environment catalyzed both by greater clarity of purpose across EU institutions.
LAMEA: The LAMEA region will cite the fastest CAGR probability 32.3% during forecast period- among all regional Cannabis Market growth rates worldwide. Colombia Brazil and Uruguay the first country to completely legalize cannabis are important producers as well for given the maturity of their regulatory frameworks over time, Latin America represents a huge production (and consumption) opportunity. The Middle East & Africa is also an early stage market which will see development along with increasing urbanization and medical awareness of cannabis.
Competitive Landscape
Major players studied in the global Cannabis Market report are medical marijuana inc., MME, LLC., Tilray, Green Thumb Industries, Ecofibre Limited, Harvest Health & Recreation, Inc, Maricann Inc., HEXO Corp., Cresco Labs, INDIVA, Stenocare, Curaleaf, Aurora Cannabis Inc., Organigram Holdings Inc., Canopy Growth Corporation. Market players have also implemented several strategies including joint ventures, collaborations, expansion, new product launches and partnerships to increase their market share in the industry. The report aids the reader in analyzing the recent developments, product portfolio, business performance and operating segments by key players in market.
Inquiry Before Buying @
https://www.alliedmarketresearch.com/purchase-enquiry/A16908
Key Recent Industry Developments
With the expansion of consumer base among Cannabis Manufacturers and other additional focuses around manufacturing, distribution and sales by the companies pertains to. This is in turn ticking investors into increasing their investment pot up for grabs even further as time goes on. Further research explores the medical use of cannabis and ways to consume it safely.
China is already an important market for industrial hemp, and it will also become an important market for industrial cannabis sooner or later. A host of major players within the sector are eagerly awaiting what many hope will be an opportunity when legislation in the Asia-Pacific region develops.
Some of the primary drivers for global Cannabis Market include initiatives taken by a range of countries to legalize cannabis, rising consumer knowledge regarding health benefits provided by cannabis & its increasing medical usage and growing R&D leads toward innovation in products. Moreover, it will further unlock the lucrative opportunities in market expansion due to legalization by Asia Pacific.
Analyst Review
Major Factors Driving the Growth of Cannabis Market The cannabis market is mainly driven by various factors such as increased legalization of marijuana in several countries, growing consumer awareness about health benefits offered by drugs and broadened medicinal applications for treating multiple ailments & symptoms.
The Cannabis Market: A structural dilemma which may be one of the worlds most compelling multi-sector markets to invest within. The Cannabis Market, offers comprehensive multi-vector growth opportunity for investors, operators and strategic planners through 2031 & beyond with North America maintaining its dominant position over four-fifths of global market share; LAMEA fastest growing region at a CAGR of 32.3%; medical cannabis recording the fastest application growth rate; preferred product group command both dominancy in terms as well as highest annual compound % Growth Rate within their Group i.e. Cannabis Extracts.
Similar Reports We Have on Food and beverages Industry:
Chrysanthemum Tea Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
https://www.alliedmarketresearch.com/chrysanthemum-tea-market-A110757
Canned Lamb Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
https://www.alliedmarketresearch.com/canned-lamb-market-A74681
Emergency Food Market: Global Opportunity Analysis and Industry Forecast, 2022-2031
https://www.alliedmarketresearch.com/emergency-food-market
CBD Wine Market: Global Opportunity Analysis and Industry Forecast, 2022-2031
https://www.alliedmarketresearch.com/cbd-wine-market-A16911
Hemp Seed Milk Market: Global Opportunity Analysis and Industry Forecast, 2024-2035
https://www.alliedmarketresearch.com/hemp-seed-milk-market-A238219
Hemp-Based Foods Market: Global Opportunity Analysis and Industry Forecast, 2024-2033
https://www.alliedmarketresearch.com/hemp-based-foods-market-A49002
Vegan Protein Powder Market: Global Opportunity Analysis and Industry Forecast, 2022-2031
https://www.alliedmarketresearch.com/vegan-protein-powder-market-A16896
Hemp Tea Market: Global Opportunity Analysis and Industry Forecast, 2022-2031
https://www.alliedmarketresearch.com/hemp-tea-market-A31565
Industrial Hemp Market: Global Opportunity Analysis and Industry Forecast, 2021-2027
https://www.alliedmarketresearch.com/industrial-hemp-market-A08684
Hemp Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
https://www.alliedmarketresearch.com/hemp-market-A185677
CBD Infused sport Drink Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
https://www.alliedmarketresearch.com/cbd-infused-sport-drink-market-A06391
CBD Gummies Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
https://www.alliedmarketresearch.com/cbd-gummies-market-A06715
Millet Snacks Market: Global Opportunity Analysis and Industry Forecast, 2022-2031
https://www.alliedmarketresearch.com/millet-snacks-market-A16885
Frozen Yogurt Market: Global Opportunity Analysis and Industry Forecast, 2022-2031
https://www.alliedmarketresearch.com/frozen-yogurt-market-A08817
Caffeine Market: Global Opportunity Analysis and Industry Forecast, 2021-2031
https://www.alliedmarketresearch.com/caffeine-market
About Us
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.
Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.
Contact:
David Correa1209 Orange Street,Corporation Trust Center,Wilmington, New Castle,Delaware 19801 USA.Int’l: +1-503-894-6022Toll Free: +1-800-792-5285Fax: [email protected]
Logo: https://mma.prnewswire.com/media/636519/5918347/Allied_Market_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/cannabis-market-estimated-to-generate-148-9-billion-by-2031–at-a-cagr-of-20-1-allied-market-research-302758931.html
Tengo varias preguntas sobre esto a ver si me podiais aclarar:
-¿Puedo hacer un ingreso regular de 800 euros y me cobran 0euos de comisiones y mto.?
-¿Puedo sacar el dinero cuando quiera?,¿todo ó tengo entendido que hay que mantener un mínimo de 100 euros los 30 meses?
-No necesito pero me obligan a sacar una tarjeta de débito que me cuesta 11 euros el primer año y 22 euros la renovación, también otra de credito que me cuesta 0 euros el primer año y 35 euros la renovación.
¿Hay que mantenerlas 13 meses?
¿Puedo cancelar alguna de ellas desde el principio?
¿Puedo cancelar alguna de ellas antes de la renovación?
¿Hay alguna tarjeta de credito más barata?
Aparte de la cuenta nómina he visto que también que para que te den la tv también se puede sacar una cuenta tarifa plana básica o personal, ¿sabeis algo de estas cuentas?¿que requisitos tienen?
Muchas gracias a todos por responder
Yo fui a informarme y te cuento. Únicamente admiten los ingresos regulares en el caso de que seas autónomo. Te abren una cuenta Tarifa Plana Cero que está exenta de comisiones y presenta alguna ventaja más. Sobre dejar un mínimo de saldo en la cuenta no es necesario, pero sí te obligan a mantener varias tarjetas durante los 30 meses con un coste aproximado de 100 euros anuales.
hola buenas!
me llamo javi y estoy dudando de que banco, me puede dar mas beficios, sin sorpresas por domiciliar la nomina, ya que llevo años en la caixa y no me da nada ningun beneficio. es mas me rechazan los prestamos que solicito, ni siquiera una targeta de credito, por alegan de que siempre esta a cero la cuenta, yo cuando cobro la nomina dejo el dinero para los pagos, y saco el resto, pues no me fio, de que un dia me quede sin dinero, ya que esta todo muy mal, corre riesgo mi dinero o mis ahorros en el banco?? muchas gracias y un cordial saludo.
javi
NO TE EXTRAÑE QUE NO TE DEN LOS PTMOS, PORQUE LO QUE VEN ES QUE NO TIENES CAPACIDAD DE AHORRO PORQUE SIEMPRE DEJAS LA CTA. EN MINIMOS, ASI NINGUN BANCO TE LO VA A CONCEDER. TAMBIEN ES VERDAD QUE LA CAIXA, COMO TANTAS OTRAS CAJAS, TIENE EL PUÑO CERRADO PARA LOS RIESGOS, PARA REMONTAR. NO TE PREOCUPES, QUE POR UNA NOMINA NO CREO QUE NINGUN BANCO SE COJA LAS MANOS. LOS QUE SE TIENEN QUE PREOCUPAR SON LOS QUE TIENEN DÉPÓSITOS Y FONDOS EN BANCOS DE DUDOSA ACTIVIDAD. LA GENTE SE PIENSA QUE PORQUE LES DEN UN 7% YA ES UN GRAN BANCO Y SE EQUIVOCAN. LO QUE LES PASA ES QUE EL BANCO DE ESPAÑA LES PRESTA EL DINERO MAS CARO Y POR ESO OPTAN POR CONSEGUIRLO EN EL MERCADO MONETARIO, Y SI EL BANCO DE ESPAÑA NO SE FIA DE ELLOS, VA Y SE FIA LA GENTE. QUE LOS BANCOS NOES LA ADMON PUBLICA, ABRAN OS OJOS.
Hola , cuando vallais al banco queos dejen lo que hay que pagar de irpf y de iva sobre el valor de la tele ya que en la mayoria de bancos esto no lo dicen y luego llagan las sorpresas .A mi ya me ha pasado con la promoción del portatil y nunca me hablaros de esto . Cuidado
Yo he estado calculando y la tele entre unas cosas y otras te sale sobre unos 250euros que tampoco regalan tanto .Hay oficinas en las que han dado la occión de poner un dinero a plazo fijo a 12meses de 9300euros o 6800euros a 18 meses.
No es ningún chollo. Te obligan a contratar dos tarjetas de crédito que tienes que pagar porque las tienes que mantener 13 meses por lo menos y además llevan unos costes desproporcionados si las utilizas. En total, no usando las tarjetas y anulándolas una vez cumplidos los 13 meses puedes ahorrar unos 38 euros con respecto al precio de ese televisor en una gran superficie. Y además luego vendrá que te cobran para hacienda la retención correspondiente, por lo que probablemente incluso en las mejores condiciones te cueste más que si ahorras un poco y lña compras directamente.
Creó que teneis toda la razón, que aqui no te regalan nada, ya que a mí me paso con unas sartenes que regalaban el banco bilbao, que al final entre el irpf y el descuento de Hacienda, al final me salieron caras, así es que no os tomen el pelo, que al final siempre esta la letra pequeña que es la que nos joroba, por no decir otra cosa.
Yo saque el portatil y ahora me he sacado la TV LCD 32. Estas promos no hay que declararlas. No es obligado domiciliar nomina. Si, meter en la cuenta 800€ todos los meses en un margen de 10 dias. Cero matacero, pero cero,cero, cero de gastos de mantenimiento, ni por recibos, ni por el correo a casa, ni por transfer. Las tarjets gratis el 1er año. Resto fuera. Dadas de baja Menos la de debito. Banesto no pierde nada, ganar, gana clientes que es el proposito de esta promo. Precio de portatil y tv 32 en mercao unos 900€ los 2. En banest 197€. Los hay mejores, nos ha jodio! portatiles a 1200€, TV LCD 32 a 1000€. Señores, son lentejas. Relacion calida-precio-promo es cojonud…….Un saludit a los viandantes.
hola , no se si llegara mi comentario pero os voi a esplicar. esto es el cuento de la abuela. mira yo tengo el portatil. y he cogio tab la tele, pero sabeis ke?, me ha pasado de todo. os esplico. primero me cobran 74 euros y 25 euros de unas tarjetas que yo no las he visto aparecer por mi casa , me cabreo con el banco. llamo y pido esplicaciones. me dicen que van en la promocion, nunca jamas nadie me informo de las tarjetas, no me devuelven el dinero. me cabreo y me dicen que llame aun numero de tefono para darlas de baja, se pasan los dias, intentamos darlas de baja. largas y larga, que si este numero de tefono que si el otro bla bla bla. conseguimos hablar y nos dicen que tenemos que cambiar el contrato a tarifa plana o no se ke historias, llamando al banco se pasan los dias, largas y largas. me cabreo y estoi por suspender todo, me dicen que si lo quiero cambiar y dar de baja las tarjetas que nunca he tenido. tengo que pagar comisiones cada seis meses de doce y pico euros, y que si no quiero que me cobren comisiones tengo que ir todos los meses al banco a hacerlo yo, ufffffffffff.aun hay mas. me dan de baja y me hacen la tarifa plana, se equivocan un monton de veces. me hacen pasar muchos cabreos.y al final cuando llego a casa me han cobrado 25, 50 euros. y llamo por telefono y se lo digo , me dicen claro por dar de baja la otra cuenta , la madre que los pario. ladrones. o sea os digo que la tele no sale regalada, se la cobran y muy bien cobrada , nadie da nada por nada. en cuento termine de pagar lo que debo quito todas las cuentas del banesto.espero que alguien me lea y que me conteste gracias .
Banesto ha jodido a mi marido y a un amigo tambien. Para mi, despues de Banco de Andalucía son los peores. Y quieran creerlo o no ni la television ni el portátil te lo regalan.. como no cumplas cualquiera de las reglas te sancionan con 300 y pico de euros.. porque nos hemos mudado de casa y los recibos domiciados se cortaron «temporalmente» la sancion fue de mas de 300 euros.. y el cabreo q te llevas cuando ves lo q te han descontado y luego para ir a reclamarlos.. y como te tratan !! en fin.. espero que Banesto sea lo primero en undirse en el fin del mundo!!
CHOLLO!!!!!!!!!JAJAJAJAJA…….NO ES NINGUN CHOLLO!!!!!!! te cobran 100 € de gastos de manipulacion, mas 150 € en tarjetas durante 2 años, mas 6 € mensuales de mantenimiento de cuenta durante 30 meses, total que pagas 630 Euros por un ordenador o una TV que su valor seguro que no llega a 500 €. Y encima si vas a cancelar la cuenta cuando cumples los 30 meses requeridos te hacen esperar dos horas para decirte que no tienen linea de telefono para dar de baja la cuenta, cosa que no para nunca cuando vas a contratarlo. Y del trato que dispensan….., es el mismo que si vas con un fajo de billetes de 500 € por los CO-JONES
Banesto «premia», menuda falacia…
No hay ningún banco que premie a nadie.
BANESTO NECESITA NUESTRAS NÓMINAS, Y EN CUANTO VAS UN POCO JUSTO, COMO BUENOS JUDÍOS Y ÁVAROS QUE SON, TE ACOSAN Y MACHACAN, Y TE SACAN HASTA LAS ENTRAÑAS EN COMISIONES.
DESPUÉS EL ESTADO APOYA A LOS BANCOS, CON LA EXCUSA DE QUE SI CAEN LOS BANCOS CAEMOS TODOS. LOS BANCOS NECESITAN UN BOICOT DE VEZ EN CUANDO, PARA QUE NO NOS RESTREGUEN POR LA CARA SUS BENEFICIOS.
POR CIERTO, LO QUE MÁS FASTIDIA A UN BANCO ES UNA RECLAMACIÓN EN LA OFICINA DEL CONSUMIDOR Y OTRA AL BANCO DE ESPAÑA.
ES POR DAR PISTAS…